[go: up one dir, main page]

EP4010000A4 - METHOD OF PREVENTING IMMUNOGLOBULIN E-RELATED DISEASE - Google Patents

METHOD OF PREVENTING IMMUNOGLOBULIN E-RELATED DISEASE Download PDF

Info

Publication number
EP4010000A4
EP4010000A4 EP20851946.2A EP20851946A EP4010000A4 EP 4010000 A4 EP4010000 A4 EP 4010000A4 EP 20851946 A EP20851946 A EP 20851946A EP 4010000 A4 EP4010000 A4 EP 4010000A4
Authority
EP
European Patent Office
Prior art keywords
related disease
immunoglobulin
preventing
preventing immunoglobulin
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20851946.2A
Other languages
German (de)
French (fr)
Other versions
EP4010000A1 (en
Inventor
Ron Kohn
Michael BRANDWEIN
Ariel Katz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Myor Diagnostics Ltd
Original Assignee
Myor Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myor Diagnostics Ltd filed Critical Myor Diagnostics Ltd
Publication of EP4010000A1 publication Critical patent/EP4010000A1/en
Publication of EP4010000A4 publication Critical patent/EP4010000A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP20851946.2A 2019-08-11 2020-08-11 METHOD OF PREVENTING IMMUNOGLOBULIN E-RELATED DISEASE Pending EP4010000A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962885263P 2019-08-11 2019-08-11
US202062989754P 2020-03-15 2020-03-15
PCT/IL2020/050875 WO2021028908A1 (en) 2019-08-11 2020-08-11 Methods for preventing an immunoglobulin e-related disease

Publications (2)

Publication Number Publication Date
EP4010000A1 EP4010000A1 (en) 2022-06-15
EP4010000A4 true EP4010000A4 (en) 2023-08-16

Family

ID=74571015

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20851946.2A Pending EP4010000A4 (en) 2019-08-11 2020-08-11 METHOD OF PREVENTING IMMUNOGLOBULIN E-RELATED DISEASE

Country Status (5)

Country Link
US (1) US20220313768A1 (en)
EP (1) EP4010000A4 (en)
CN (1) CN114728035A (en)
MX (1) MX2022001748A (en)
WO (1) WO2021028908A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1169838C (en) * 2001-12-14 2004-10-06 中国科学院微生物研究所 Acetylmannan and its preparation method and application
KR100723251B1 (en) * 2005-03-18 2007-05-29 전숙영 A pharmaceutical composition for the treatment of allergic diseases, use thereof, and a method for treatment of allergic diseases
ES2494928T3 (en) * 2007-09-21 2014-09-16 Pharmabrand S.A. Composition comprising mucilaginous polysaccharides derived from Aloe barbadensis combined with liposomes, method for obtaining them and their use as sunscreen, an anti-acne agent, an epidermal regenerator and a moisturizer
GB2459121A (en) * 2008-04-10 2009-10-14 Prime Interaction Holdings Ltd A product for topical administration
US10272108B2 (en) * 2011-05-05 2019-04-30 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
EP4010000A1 (en) 2022-06-15
MX2022001748A (en) 2022-04-07
WO2021028908A1 (en) 2021-02-18
CN114728035A (en) 2022-07-08
US20220313768A1 (en) 2022-10-06

Similar Documents

Publication Publication Date Title
EP3998106C0 (en) SYSTEMS AND METHODS FOR DETERMINING A REGION OF INTEREST OF A SUBJECT
EP3893931A4 (en) METHODS FOR USE OF ANTI-TREM2 ANTIBODIES
EP3877192C0 (en) METHOD FOR MANUFACTURING COMPONENTS OF A SAFETY DEVICE
EP3851549A4 (en) RAIL AND METHOD OF MAKING A RAIL
EP3839494C0 (en) METHOD OF CHARACTERIZING A WELD
EP3831793A4 (en) METHOD OF MANUFACTURING A GLASS UNIT
EP3699585C0 (en) WELD INSPECTION PROCEDURE
DE112018000604T8 (en) Method for determining a configuration setting of a source of ionizing radiation
EP3878968A4 (en) PROCEDURE FOR SEQUENCING POLYNUCLEOTIDS
EP3833322A4 (en) METHOD OF MAKING A COATING
EP3751332A4 (en) LENS AND METHOD OF MAKING A LENS
EP3675624A4 (en) METHOD OF INCREASING DISEASE RESISTANCE OF A PLANT
EP3889374A4 (en) METHOD OF MANUFACTURING BUILDINGS
EP3858817A4 (en) METHOD OF MAKING AN AMIDATE COMPOUND AND AMIDATE COMPOUND
EP3756113A4 (en) METHOD AND SYSTEM FOR PERFORMING A SIMULATION OF A RETURN CABLE MOVEMENT
EP3853912C0 (en) PROCESS FOR POST-TREATMENT OF AN ABSORBER LAYER
EP3894768C0 (en) METHOD FOR CRYOHARDENING
EP3423839A4 (en) METHOD FOR DETERMINING THE RISK OF EARLY BIRTH
EP3871737C0 (en) METHOD FOR MANUFACTURING AN ACOUSTIC LENS
EP3765645A4 (en) METHOD OF MANUFACTURING AN ALUMINUM-SCANDIUM ALLOY
EP3987353C0 (en) METHOD FOR PRODUCING BRIDGE WAVEGUIDES
EP3791134A4 (en) SYSTEM AND PROCEDURE FOR MANAGING A VARIETY OF VEHICLES
EP3947692A4 (en) METHOD OF MODIFYING TRANSLATION
EP4469618C0 (en) EMISSIVITY-CORRIDATED PYROMETRY METHOD
EP3769231C0 (en) Method and system for providing a generic request interface

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220307

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230713

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 37/00 20060101ALI20230707BHEP

Ipc: A61K 39/00 20060101ALI20230707BHEP

Ipc: A61B 5/00 20060101ALI20230707BHEP

Ipc: A61K 39/35 20060101ALI20230707BHEP

Ipc: A61K 8/06 20060101ALI20230707BHEP

Ipc: A61Q 19/00 20060101ALI20230707BHEP

Ipc: A61P 11/06 20060101ALI20230707BHEP

Ipc: A61P 37/08 20060101ALI20230707BHEP

Ipc: A61P 37/04 20060101ALI20230707BHEP

Ipc: A61K 36/886 20060101AFI20230707BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250715